(Q37958645)

25 August 2017

Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment (English)

1 reference

X-linked hypophosphatemic rickets

25 August 2017

1 reference

Amaka Offiah

3

0 references

Sian Ellard

object named as

Sian Ellard

6

0 references

Catherine Quinlan

1

object named as

Catherine Quinlan

1 reference

25 August 2017

Katie Guegan

2

1 reference

25 August 2017

Richard O' Neill

4

1 reference

25 August 2017

Melanie P Hiorns

5

1 reference

25 August 2017

Detlef Bockenhauer

7

1 reference

25 August 2017

William Van't Hoff

8

1 reference

25 August 2017

Aoife M Waters

9

1 reference

25 August 2017

language of work or name

1 reference

20 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

27

1 reference

25 August 2017

581-588

1 reference

25 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-011-2046-z

25 August 2017

0 references

cites work

PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets.

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Bone Response to Phosphate Salts, Ergocalciferol, and Calcitriol in Hypophosphatemic Vitamin D-Resistant Rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Evaluation of stature development during childhood and adolescence in individuals with familial hypophosphatemic rickets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Final height of Japanese patients with X-linked hypophosphatemic rickets: effect of vitamin D and phosphate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Effects of therapy in X-linked hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Hypophosphataemic rickets: final height and clinical symptoms in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

A clinical and molecular genetic study of hypophosphatemic rickets in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

More evidence for hyperoxaluria in phosphate-treated X-linked familial hypophosphataemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Mutational Analysis and Genotype-Phenotype Correlation of the PHEX Gene in X-Linked Hypophosphatemic Rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-2046-Z

Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets

21 January 2018

1 reference

12 December 2020

Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1α-hydroxyvitamin D3

1 reference

12 December 2020

Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.

1 reference

12 December 2020

Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia

1 reference

12 December 2020

Growth in children with X-linked hypophosphataemic rickets

1 reference

12 December 2020

Nephrocalcinosis and its relationship to treatment of hereditary rickets

1 reference

12 December 2020

Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3

1 reference

12 December 2020

Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice

1 reference

12 December 2020

Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets

1 reference

12 December 2020

Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia

1 reference

12 December 2020

Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse

1 reference

12 December 2020

Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets

1 reference

12 December 2020

Renal calcium deposition in children: sonographic demonstration of the Anderson-Carr progression

1 reference

12 December 2020

Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren

1 reference

12 December 2020

Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice

1 reference

12 December 2020

10.1007/S00467-011-2046-Z

Identifiers

DOI

1 reference

release_r4vbek7coffwhd22kkjxmdvova

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r4vbek7coffwhd22kkjxmdvova

24 November 2022

mapped directly with Wikidata item

1 reference